1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for KAPA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2025. Start Trial.
Date Value
September 18, 2026 -81.56%
September 17, 2026 -84.61%
September 16, 2026 -83.94%
September 15, 2026 -83.27%
September 14, 2026 -85.06%
September 11, 2026 -86.05%
September 10, 2026 -87.03%
September 09, 2026 -87.96%
September 08, 2026 -86.33%
September 04, 2026 -83.04%
September 03, 2026 -83.66%
September 02, 2026 -83.99%
September 01, 2026 -82.54%
August 31, 2026 -82.22%
August 28, 2026 -81.18%
August 27, 2026 -79.58%
August 26, 2026 -78.33%
August 25, 2026 -79.82%
August 24, 2026 -80.34%
August 21, 2026 -75.21%
August 20, 2026 -72.42%
August 19, 2026 -71.85%
August 18, 2026 -73.49%
August 17, 2026 -72.96%
August 14, 2026 -72.50%
Date Value
August 13, 2026 -66.36%
August 12, 2026 -68.34%
August 11, 2026 -63.11%
August 10, 2026 -64.43%
August 07, 2026 -59.79%
August 06, 2026 -59.91%
August 05, 2026 -66.33%
August 04, 2026 -65.59%
August 03, 2026 -66.28%
July 31, 2026 -65.99%
July 30, 2026 -68.10%
July 29, 2026 -65.25%
July 28, 2026 -64.74%
July 27, 2026 -66.69%
July 24, 2026 -69.35%
July 23, 2026 -69.60%
July 22, 2026 -69.64%
July 21, 2026 -64.55%
July 20, 2026 -70.20%
July 17, 2026 -69.61%
July 16, 2026 -68.82%
July 15, 2026 -72.82%
July 14, 2026 -50.37%
July 13, 2026 -52.41%
July 10, 2026 -50.39%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 10.24%
Alnylam Pharmaceuticals, Inc. -47.02%
Anika Therapeutics, Inc. 132.8%
Savara, Inc. 49.17%
Vericel Corp. 25.65%